Admissions

  • Illinois 
  • U.S. District Court for the Northern District of Illinois

Education

Georgetown University (A.B., cum laude); Phi Beta Kappa

University of Chicago Law School (J.D.)

Profile

Chris Manning is a partner at Burke, Warren, MacKay & Serritella, P.C. Mr. Manning concentrates his practice in the areas of pharmaceutical/biotech, health care, corporate/securities law, and municipal finance, where he has extensive experience in merger and acquisitions in the banking, insurance and pharmaceutical industries, corporate governance, pharmaceutical product development and commercialization, securities underwriting, and the financing of a wide array of public and private transactions. Mr. Manning represents companies in the United States and Europe in a wide-ranging practice that focuses on start‑ups, product line acquisitions, and general corporate law.  In addition to serving as the outside counsel for the U.S. subsidiaries of several major international pharmaceutical companies, Mr. Manning has been involved in all phases of the start‑up, funding, expansion, and eventual sale of numerous U.S.- and European-based companies. Mr. Manning serves as the leader of Burke Warren's municipal finance group and Co-chair of its Health Care practice.

Mr. Manning regularly speaks on the duties of officers and directors and corporate governance matters. He has previously served on the Illinois Secretary of State Corporate Law Advisory Committee.

Experience

  • Over thirty years of experience in negotiating commercial contracts for companies including license agreements, supply agreements, distribution agreements, co-promotion agreements, collaboration agreements, employment and consulting agreements, confidentiality agreements, CMO agreements, intra-company agreements, etc.
  • Represented multiple insurance brokers in sale of their businesses
  • Represented large Midwest-based charitable foundation in an IRS-mandated divestiture of operating assets over a five year period
  • Represented the seller in a corporate inversion involving a U.S. pharmaceutical company combining with an Irish-based pharmaceutical company
  • Serve as outside U.S. general counsel for commercialization matters for an Israeli-based pharmaceutical company. 
  • Served as outside general counsel to Irish based pharmaceutical company
  • Represented U.S. based pharmaceutical company in setting up U.S. drug distribution program
  • Represented buyers and sellers in dozens of drug-related, product line purchases and sale
  • Represented U.S. based pharmaceutical company in the negotiation of a technology license agreement with a South Korean company for the development and commercialization of a product in the U.S. and Canada.  
  • Represented sale of U.S. pharmaceutical company to U.S. subsidy of Swedish pharmaceutical company
  • Served as lead counsel in drug company IPO
  • Served as underwriters counsel in various bond offerings by municipal issues, including as underwriters counsel in more than $3,000,000,000 of bond offerings for the O’Hare Airport Modernization Program
  • Negotiated and structured debt arrangements for emerging and expanding companies
  • Structured venture capital investments in start‑up companies

Honors & Awards

  • AV Preeminent Rating by Martindale Hubbell every year since 1994
  • Illinois Super Lawyer 2005–2014
  • Member of the Illinois Secretary of State’s Corporate Law Advisory Committee that developed the Illinois Limited Liability Company Act

Professional/Community

  • Member of local church finance committee
  • Illinois Secretary of State Business Corporation Acts Advisory Committee
  • The Lawyers Club

Pressroom

330 North Wabash Avenue, Suite 2100
Chicago, Illinois 60611-3607
T: 312.840.7000
F: 312.840.7900